BRD2 and ovarian carcinoma: Thus, gro-α shRNA-loaded nanoparticles conjugated with FSH peptides could inhibit the proliferation, invasion, and migration abilities of FSHR-positive ovarian cancer cells, which may be due to the enhanced down-regulation of gro-α mediated by the nanoparticle complex.